A QALY is [still] a QALY is [still] a QALY?
Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained. This paper, taking...
Source: BMC Medical Ethics - Category: Medical Ethics Authors: Hamideh Mahdiani, Nikolai M ünch and Norbert W. Paul Tags: Comment Source Type: research
More News: Immunotherapy | Medical Ethics